Crossmark

The effect of treatment cessation on HBsAg negativity in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)id analogues for more than three years

Crossref DOI link: https://doi.org/10.1186/s12879-026-12667-2

Published Online: 2026-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Senol Yilmaz, Aydeniz

Turker, Nesrin
License Information

Text and Data Mining valid from 2026-01-27

Version of Record valid from 2026-02-18
More Information

Article History

Received: 23 May 2025

Accepted: 19 January 2026

First Online: 27 January 2026

Declarations

:

: Our study was approved by the Ethics Committee of İzmir Katip Çelebi University Atatürk Training and Research Hospital on 04.04.2022 with the number GOKAE-0111. This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent to participate was obtained from all individual participants included in the study.

: All authors approved the final manuscript for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below